In mouse model of MLL-AF9 AML, developed in Foxp3DTR mice (which enable depletion of Treg by diphtheria toxin injection; DTR - diphtheria toxin receptor), depletion of Treg has reduced leukemic burden and prolonged survival of mice [174]. This evidence concerns the gene KMT2A and acute myeloid leukemia.